8/31/2010

Pfizer, Cytokinetics and other pharmaceutical firms are trying to develop medicines that can mimic the muscle-building ability of testosterone and serve as an alternative to anabolic steroids. Most of the drug candidates have been trialed only in early-stage studies and have faced numerous obstacles.

Related Summaries